POST Online Media Lite Edition


Pfizer to build COVID-19 vaccine manufacturing plant in Ireland

Christian Fernsby |
Pfizer will build a plant in Ringaskiddy, Cork to support its clinical trials as part of a €300 ($355) million investment in Ireland.

Article continues below

Topics: PFIZER    IRELAND   

The U.S. drug giant announced it would expand capacity in Ireland this week, explaining the investment included the initial stage of a project to construct the clinical trial supply facility at its existing Ringaskiddy site.

At present the Ringaskiddy facility makes and exports bulk pharmaceutical and products. It was set up in 1969 to produce food chemicals, including citric acid and gluconate products.

Pfizer will also expand capacity at its biotechnology focused facility in Grange Castle in Dublin and its solid dose plant in Newbridge, Kildare.

The firm said it will add manufacturing and lab capacity, adding it would introduce new technologies to ensure it “is ready to support the next wave of medical innovations.”

The expansion project is expected to create 300 jobs over the next two to three years.

What to read next

Pfizer completes Hospira acquisition
AstraZeneca board rejects Pfizer's final proposal
Pfizer pledges to continue vaccine supply even if Italy files lawsuit